Thirty-four insulin and incretin-naive patients with type 2 diabetes mellitus ( body mass index 25-45 kg/m ( 2 ) ) who received metformin for at least two months were randomized to exenatide or insulin glargine treatment arms and followed-up for 26 weeks .